This study describes the association of myostatin with ACLF development; the manuscript aimed to provide evidence that muscle impairment, as indicated by myostatin levels, is associated with increased severity of cirrhosis, ACLF, and survival. The gene discussed is MSTN; the disease is Cirrhosis.